All I'm Asking for Is Rigor

Oh boy, I hit a nerve. My last two days of donning the bear suit and imitating the bears has brought on a cacophony of critics, all of whom think that I am attacking them personally! That's right, they think I have read them, seen them and heard them and that I am spoofing them or making fun of them.

Moreover, they think that I am wildly bullish and that I am mocking them for not wanting to buy things here.

In reality, what I was simply saying and have been saying is that the spin on news has cost you money. The news backdrop of good car sales, good existing-home sales, good GDP, good retail sales, good industrial earnings and good pro-business political developments (anti-punitive health care reform) just hasn't mattered to some commentators. That's what I am grousing about. And I have been demonstrating, empirically, how that past spin has kept you out of big moves as diverse as those in Kohl's (KSS - commentary - Trade Now) and Lauren (RL - commentary - Trade Now) to Apple (AAPL - commentary - Trade Now) and Google (GOOG - commentary - Trade Now) and Caterpillar (CAT - commentary - Trade Now) and Emerson (EMR - commentary - Trade Now), Cooper (CBE - commentary - Trade Now) and Chevron (CVX - commentary - Trade Now).

Those are pretty much statements of fact.

What I think the critics don't get is that if we get some really awful data, like no new jobs created soon, then I think those stocks won't hold up. More important, I have switched directions away from the three-legged stool of tech, finance and oil, which I believe have stalled out here pending some sign of job growth, in favor of the four-legged chair of Procter (PG - commentary - Trade Now), WellPoint (WLP - commentary - Trade Now) (anticipating Pelosi failure), McDonald's (MCD - commentary - Trade Now) and General Mills (GIS - commentary - Trade Now). Subsequently, because of either good quarters or change in Washington, I have added Kimberly-Clark (KMB - commentary - Trade Now), Bristol Myers (BMY - commentary - Trade Now) and Pfizer (PFE - commentary - Trade Now).

ALL JIM CRAMER BLOG ENTRIES | POST A COMMENT | READ COMMENTS  

---

Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here.

TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com.